Skip to main content

spiral-therapeutics-logo

Early-stage pharmaceutical company Spiral Therapeutics received $3.7 million in new investment as it looks to advance treatments for hearing loss and other inner ear disorders.

{iframe}https://technical.ly/baltimore/2018/12/12/camden-partners-nexus-co-leads-3-7m-investment-in-company-developing-therapeutics-to-treat-hearing-loss/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=68289659&_hsenc=p2ANqtz-8P-n_gc4BxcGtg4K2sV7PlZ6E0Lp8ODhDcUqw1dC4OWZgRPMXd7GMMf4v-B470xwx1Ffr8Fmyv7mfuglQYVQJ3lROYUg&_hsmi=68289659{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.